US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Altimmune Inc

Recent news which mentions Altimmune Inc

Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Altimmune Inc Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Health care industry Health & Science Gilead Sciences Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Oracle Corp Health care industry Health & Science
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags US: News Novo Nordisk A/S Business
From CNBC.com News
Cramer's Lightning Round: Quanta Services is 'terrific'
Tags Altimmune Inc Markets Nutanix Inc
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Altimmune Inc Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Datadog is a 'dynamite company'
Tags Investment strategy Business Investment Strategy
From CNBC.com News
Cramer's Lightning Round: Affirm is a buy
Tags S&P 500 GS Acquisition Holdings Corp Stock markets
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Altimmune Inc Breaking news Health & Science
From CNBC.com News